Advertisement
Advertisement

RLAY

RLAY logo

Relay Therapeutics, Inc. Common Stock

13.52
USD
Sponsored
-1.02
-7.02%
Jun 05, 16:00 UTC -4
Closed
exchange

After-Market

13.23

-0.29
-2.14%

RLAY Earnings Reports

Positive Surprise Ratio

RLAY beat 14 of 24 last estimates.

58%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$658.37K
/
-$0.40
Implied change from Q1 26 (Revenue/ EPS)
-78.05%
/
-2.44%
Implied change from Q2 25 (Revenue/ EPS)
-2.75%
/
-2.44%

Relay Therapeutics, Inc. Common Stock earnings per share and revenue

On May 05, 2026, RLAY reported earnings of -0.41 USD per share (EPS) for Q1 26, missing the estimate of -0.38 USD, resulting in a -6.66% surprise. Revenue reached 3.00 million, compared to an expected 2.61 million, with a 14.89% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 658.37 thousand USD, implying an decrease of -2.44% EPS, and decrease of -78.05% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
MediWound Ltd.
Report Date
May 27, 2026 For Q1 26
Estimate
-$0.66
Actual
-$0.23
Surprise
+65.49%
logo
Cardiol Therapeutics Inc. Class A Common Shares
Report Date
May 26, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q1 2026, Relay Therapeutics, Inc. Common Stock reported EPS of -$0.41, missing estimates by -6.66%, and revenue of $3.00M, 14.89% above expectations.
The stock price moved down -0.62%, changed from $13.00 before the earnings release to $12.92 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 9 analysts, Relay Therapeutics, Inc. Common Stock is expected to report EPS of -$0.40 and revenue of $658.37K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement